Vasorelaxant Effect of Metformin in Human Umbilical Artery In Vitro
Abstract
Objective: To evaluate the effect of metformin on the vasomotion of human umbilical artery (HUA) in vitro.Study Design: Experimental study (Ex-vivo Pharmacodynamic study).Place and Duration of the Study: Department of Pharmacology of Azra Naheed Medical College - Superior University, and Combined Military Hospital, Lahore from Nov 13, 2024 to Apr 30, 2025.Materials and Methods: A total of 24 HUA samples were obtained from 24 different donors to ensure biological independence, and were divided into 4 groups with a sample size of 6 in each. Fresh HUA tissues with intactendothelium, and without endothelium were suspended in Kreb's solution, pH 7.4. A force transducer (MLT0420) connected with an amplifier (AD Instruments Bridge Amps) was used to record isometric tension.The vasorelaxant responses of HUA to metformin (1-20 μM/l) were noted. In another setup the responses of metformin in KCl (60μM) precontracted HUA rings were recorded. The response of KCl + PGE were taken as 2 standard.Results: The effect of metformin (1-20 μM/l) on HUA with intact endothelium showed significant relaxation (p<0.0001) IC was 7.031. The HUA ring with intact endothelium presented with better relaxation than rings 50 without endothelium. The IC were 7.031 and 0.6821 respectively. In case of KCl (60μM) pretreated HUA rings, 50 the findings of metformin and PGE were comparable showing IC 5.739 and 6.248 respectively. 2 50Conclusion: Metformin with KCl exhibited the strongest vasorelaxation followed by…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.